|
HS Code |
206186 |
| Productname | 6,7-Dimethoxy-3,4-Dihydroisoquinoline Hydrochloride |
| Casnumber | 3449-17-8 |
| Molecularformula | C11H14ClNO2 |
| Molecularweight | 227.69 g/mol |
| Appearance | White to off-white solid |
| Solubility | Soluble in water |
| Meltingpoint | 218-222 °C |
| Storagetemperature | Store at 2-8°C |
| Purity | Typically ≥98% |
| Synonyms | 6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride |
| Smiles | COc1cc2CCN=C(c2cc1OC)Cl |
| Inchikey | KYPEWIPBUUPIIJ-UHFFFAOYSA-N |
As an accredited 6,7-Dimethoxy-3,4-Dihydroisoquinoline Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, sealed HDPE bottle containing 25 grams of 6,7-Dimethoxy-3,4-Dihydroisoquinoline Hydrochloride; labeled with product details and safety information. |
| Shipping | 6,7-Dimethoxy-3,4-Dihydroisoquinoline Hydrochloride is shipped in tightly sealed containers to prevent moisture, contamination, and degradation. All packaging complies with chemical safety regulations. The shipment includes proper labeling, safety data sheets (SDS), and hazard information. Temperature and handling instructions are specified as required, ensuring secure and compliant delivery. |
| Storage | 6,7-Dimethoxy-3,4-Dihydroisoquinoline Hydrochloride should be stored in a tightly closed container, protected from light and moisture. Keep the chemical at room temperature (20–25°C) in a cool, dry, and well-ventilated area. Avoid exposure to strong acids, bases, and oxidizing agents. Store away from incompatible substances and ensure proper labeling to prevent accidental misuse. |
Applications of 6,7-Dimethoxy-3,4-Dihydroisoquinoline Hydrochloride in Industrial Manufacturing6,7-Dimethoxy-3,4-Dihydroisoquinoline Hydrochloride supports advanced synthesis pathways for specialty chemicals and pharmaceutical intermediates. As a primary manufacturer, we formulate, purify, and control quality to meet strict industrial demand across multiple downstream sectors, ensuring consistent reactivity and compliance from batch to batch for complex conversion steps in regulated environments. 1. Pharmaceutical API Intermediate ProductionThis material serves as a key building block in the multi-step synthesis of high-value alkaloid derivatives. Process engineers introduce it during intermediate coupling or cyclization stages, where its structural features support selective transformations essential for producing drug precursor molecules targeting neurology and oncology indications. Controlled addition ensures impurities remain within drug master file limits, with batch records traceable for regulatory audits. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical SynthesisProducers of active crop protection ingredients utilize this compound during nitrogen heterocycle formation, facilitating the construction of bioactive rings in herbicide and fungicide molecules. Technicians precisely meter the raw material to balance reactivity and minimize unwanted side reactions, supporting consistent throughput and batch reproducibility for regulated product lines targeting seed treatment and foliar application products sold globally. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Fine Chemical and Dye SynthesisManufacturers developing specialty dyes for electronic, textile, and photonic applications employ this compound as a core reactant in the synthesis of methoxy-isoquinolinyl colorants. Operators add the raw material in stoichiometric ratios to produce intensely colored chromophores with improved fastness properties, tailoring the feedstock’s input based on downstream sulfonation, acylation, or metal-complexation requirements for performance in end-product matrices. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Research and Custom Synthesis ServicesChemical contract research organizations and pilot plant operators utilize this compound in small- to medium-scale synthesis projects, especially for proprietary heterocyclic scaffolds across medicinal chemistry and advanced material research. Chemists handle batch records in traceable lot numbers and determine feed ratios to allow rapid modification of reaction parameters, supporting iterative lead optimization and scale-up studies required for patent filings and experimental assessments. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 6,7-Dimethoxy-3,4-Dihydroisoquinoline Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
We manufacture 6,7-Dimethoxy-3,4-Dihydroisoquinoline Hydrochloride with the aim of supporting researchers and chemical developers seeking reliable, well-characterized intermediates. For years in this industry, we have seen the demand grow for high-purity isoquinoline derivatives—especially in the fields of medicinal chemistry, specialty chemical synthesis, and advanced materials science. Our production process focuses not just on yield, but purity and consistency, with rigorous testing standards at every stage.
This compound, known by its structure with methoxy groups at the 6 and 7 positions on the dihydroisoquinoline scaffold, occupies a valuable spot among isoquinoline derivatives. The crucial hydrochloride salt brings improved stability and handling, especially in multi-step syntheses that require reproducible results batch to batch. Our experience tells us that stability matters as much as purity in a research setting—minimizing decomposition and maximizing confidence in experimental results.
Researchers often seek this particular derivative to serve as a functional building block, owing to its versatile reactivity and defined electronic properties. Medicinal chemists value the dimethoxy substitution pattern for directing further functionalization and influencing biological profiles. We have observed that the hydrochloride form surpasses free bases in ease of storage, dosing accuracy, and compatibility with both laboratory and industrial workflows. We always confirm salt identity and counter-ion content by NMR and Karl Fischer titration, because the difference in salt form can change everything during a downstream reaction or purification.
Over the years, our clients have shared feedback about assay and moisture control. Some struggle when suppliers neglect the fine points of drying, which can impact sensitive syntheses that follow. To address this, our facility maintains controlled humidity throughout the packaging area, and we monitor each lot with strict moisture limits. Purity above 98% by HPLC is our usual release specification, but for custom projects we have produced materials at even higher thresholds. No corners cut, no shortcuts hidden.
We have tried products from trading houses and anonymous bulk suppliers in the past. Many offer “mystery lots” with little traceability, variable purity, or ambiguous salt forms. We learned early that batch records, trace impurity tracking, and full spectral assignment make all the difference to customers engaged in drug discovery or process development. Our certificates document NMR, LC-MS, and IR data with each batch, so anyone using our product follows a clear path from material acquisition through to their end result.
Some competitors offer only the free base or generic hydrochloride salts without significant analysis. In contrast, we test for all relevant impurities such as N-oxides, demethylated species, and residual solvents. Feedback from peptide synthesis and small-molecule customers emphasized the value of minimizing trace side products, which can derail an entire synthetic campaign. In our process, reaction conditions and purification steps are designed to avoid over-oxidation or incomplete quenching—common pitfalls that create lingering doubts about the consistency of a material.
Our team includes experienced synthetic chemists who understand the landscape of isoquinoline chemistry from decades in the lab. We have fine-tuned conditions for forming the hydrochloride salt directly from purified base using strictly stoichiometric quantities of hydrogen chloride gas, then crystallizing under anhydrous conditions. We routinely analyze each batch for residual organic solvents, using headspace GC, and report findings transparently. Customers who once thought they had to accept variable quality now tell us they can focus on research instead of troubleshooting input materials.
Chemical development does not pause for inconsistent quality. We listen to the needs of our R&D customers, who often operate within tight project schedules and budget frames. Many tell us about lost time or resources chasing after inconsistent materials from less specialized suppliers. This feedback drives us to enhance our batch traceability and to invest in analytical characterization that simplifies regulatory documentation for our clients. Record-keeping standards on our end make third-party audits and technology transfers smoother.
Synthesis groups in academic research or pharma innovation rely on reproducible catalysts and intermediates. This hydrochloride salt convinces many first-time clients after a single trial batch. Once they see consistent chromatographic profiles, reproducible melting points, and complete documentation, they return for the reliability that supports their discoveries. Our experience tells us that documentation alone—while essential—has to pair with genuine attention to manufacturing detail. Quality always starts on the production floor and is validated in the testing lab, never the other way around.
Some see specialty chemicals as commodities, interchangeable and undifferentiated. Our experience suggests otherwise. The profile of impurities, the exact salt form, and the analytical documentation can determine the success or failure of an entire project. For example, a project in medicinal chemistry might hinge on a subtle difference in NMR spectrum, which only shows up if starting materials are pure and well-characterized. Our process tracks every variable, and each batch undergoes full spectroscopic confirmation by 1H and 13C NMR—assigned and reported—so our customers know exactly what flows into their process.
Batch-to-batch consistency matters for groups engaged in route scouting or scale-up. Many development chemists tell us their route selection is affected by early reproducibility issues traced back to input materials. Once purchasing switches to our hydrochloride salt, they eliminate one cause of unexpected variability in yield or selectivity. We see our job as more than just shipping product; it’s about anticipating and minimizing the risks that can cascade through a chemistry workflow.
Our manufacturing model centers on reliability. We employ a closed reactor system with in-line monitoring of temperature and pressure, designed for tight control over reaction kinetics. Batch records specify each step’s conditions, and we log every solvent and reagent lot number for full traceability. The resulting hydrochloride salt generally features a melting point in the anticipated range, with minimal drift between lots. Every new process modification we consider runs through parallel stress testing and stability assessment—this gives us, and our customers, greater certainty.
Specifications reach beyond basic purity reporting. Multiple analytical specialists review HPLC and NMR data, confirming both the identity and the absence of critical impurities. This dual approach, adopted after learning from customer QC teams, avoids the trap of confusing high assay numbers with total fitness-for-purpose. Compound identity, salt stoichiometry, and trace residue levels all receive careful documentation.
Our team’s practical background in synthesis, crystallization, and process scale-up informs how we optimize every stage. We know from decades of plant operation that solvent choice, temperature ramp, and agitation speed all play subtle roles in product formation. The result is a hydrochloride salt that not only checks out by HPLC purity but delivers real-world performance in downstream reactions. Customers benefit from fewer purification headaches, cleaner isolation of target products, and higher overall reliability in their pipelines.
Product integrity does not end at the reactor. Many overlook the final steps between crystallization and shipment. Changes in humidity, exposure to light, or contact with reactive packaging materials have cost clients dearly before they came to us. Delays, failed analysis, even lost funding have all followed from neglected post-processing. That’s why we oversee each detail, from site-controlled desiccant-packed containers to careful choice of non-reactive inner liners. Customers receive a material that reads the same on their own analysis as it did on ours.
Clients have told us about loss of batch homogeneity and gradual decomposition from sources as subtle as improper storage temperatures. Our packaging and labeling both include details on best-practices for handling, supported by our own internal accelerated aging studies. This approach has reduced client complaints about “mystery” analytical drift and reduced the repeat order cycle time, because fewer surprises arise during project work.
6,7-Dimethoxy-3,4-Dihydroisoquinoline Hydrochloride represents a key intermediate for medicinal chemists, especially in alkaloid synthesis and new molecular entity exploration. During collaborations with both academic and pharmaceutical labs, we have watched teams build complex heterocycles and novel small molecules from our product. Many relay that the well-defined salt form helps avoid side-reactions, especially unwanted hydrolysis or base-promoted rearrangement, common with less stable analogues.
The dimethoxy substitution pattern plays a role in modern pharmacophore design—offering a platform to explore new structure-activity relationships. We support projects ranging from proof-of-concept studies to pipeline syntheses for regulatory submission, providing both standard and custom-tailored batch sizes. Clients also use this hydrochloride salt in the production of specialty chemicals where regioselective transformations matter.
Synthetic chemists often struggle with inconsistent salt forms, poorly controlled counter-ion ratios, or variable reactivity in isoquinoline compounds from bulk suppliers. We came up against the same issues years ago while running our own process development projects. Too often, a reaction would stall or throw off unexpected by-products, only to discover that the input material was off-spec, or an unidentified salt or hydrate had snuck through.
To combat these challenges, we refined both manufacturing and analytical methods. Each batch of 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride is produced under controlled, documented conditions, and shipped only after in-house confirmation of its full analytical profile. Clients require not just “material to work with” but the confidence that what they receive will not add new variables or obstacles to their already challenging projects.
We report solvent residues, moisture content, and chromatographic purity transparently and freely provide historical batch data for clients who require it for regulatory filings. Our difference comes in how every team member understands what’s at stake for each customer—time, money, reputation, and sometimes careers ride on the quality of what comes out of our plant. Ensuring the right salt form, minimizing batch-to-batch variability, and maintaining strict impurity controls are the ways we support the broader community of innovators.
Customers’ voices have always influenced our process improvements more than any textbook or standard operating procedure. Over years of direct feedback, several pain points stood out—unannounced excipient changes from traders, unexplained shifts in analytical fingerprinting, or insufficient documentation from resellers across the industry. By realigning our output to their practical needs, we have carved out a path of transparency and dialogue rather than faceless commodity exchanges.
Some of our refinement projects began in direct response to a single client’s report of subtle reactivity shifts during palladium-catalyzed coupling. They suspected, correctly, that an unaccounted impurity in a commercial lot had shifted their yield profile. Open communication allowed us to replicate, diagnose, and resolve the issue, ultimately refining both our process and analytical methods. Their next five projects succeeded, and our own staff applied these lessons to compound classes beyond isoquinolines.
By retracing analytical and batch-level details with clients, we promote a partnership culture that values continuity over one-time sales. Our confidence as a manufacturer stems from knowing that a client’s problem can become the seed for our next internal innovation.
We recognize that behind every vial of 6,7-Dimethoxy-3,4-Dihydroisoquinoline Hydrochloride lies a larger research goal—whether that’s developing new pharmaceuticals, innovating chemical methodologies, or teaching the next generation of chemists. Our responsibility rests in ensuring that upstream purity and characterization leave no doubt by the time the compound enters our customer’s workup flask. We do not see ourselves as distant producers, but as collaborators in the process of discovery.
Because every project sets its own standards, our facility maintains strong flexibility, ready to respond to requests for alternate batch sizes, purity levels, or documentation. Clients rarely benefit from “cookie-cutter” solutions. Our ability to adapt, communicate, and deliver predictable quality reflects years of continuous improvement and a culture that prizes direct experience over theoretical perfection.
Trust in the chemical supply chain has often been fragile—built on little more than promises and brittle assurances, and too easily broken by a single poorly-documented shipment. Our presence as the manufacturer means no intermediaries or foggy lines of responsibility. From the synthetic bench to the packaging line, our process leaves nothing to chance or anonymous hands. Clients know their questions reach those directly responsible for the work, not distant customer service scripts.
This approach translates into an ongoing relationship with our clients, many of whom graduate from one-off samples to year-on-year contracts as new projects develop. Consistency in analytical documentation, an open channel for discussing batch specifics, and a demonstrable understanding of specialty chemical needs form the pillars of our ongoing development efforts.
Manufacturing specialty chemicals like 6,7-Dimethoxy-3,4-Dihydroisoquinoline Hydrochloride has taught us that every batch is an intersection of intention, technology, and the real-world needs of scientists around the globe. We have learned to see each re-order not just as an endorsement, but an opportunity to improve—the difference between average and exceptional lies in the care and transparency built into every step.
Our hope is that clients continue to view us not only as a source of reliable materials, but as experienced partners whose expertise stands behind every lot. Comprehensive analytical data, open communication, process flexibility, and the visible difference in batch-to-batch performance remain the ways we live up to that trust. This is how we meet the challenges of specialty chemical supply, one batch at a time.